Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
18 hedge funds and large institutions have $10.3M invested in Alimera Sciences in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 0 closing their positions.
4,280% more capital inflows, than outflows
Capital inflows: $3.43M | Capital outflows: $78.3K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
18.11% more ownership
Funds ownership: 29.3% → 47.41% (+18%)
13% more funds holding
Funds holding: 16 → 18 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$3.22M |
| 2 |
Renaissance Technologies
New York
|
+$65K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.3K |
| 4 |
Bridgeway Capital Management
Houston,
Texas
|
+$45.9K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$26.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$30.6K |
| 2 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$18.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.6K |
| 4 |
JP Morgan Chase
New York
|
-$11.5K |
| 5 |
Tower Research Capital (TRC)
New York
|
-$1.2K |
ALIM Hedge Fund Activity: Q2 2023 in Review
18 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2023, worth a combined $10.3M — up 138% from $4.3M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ALIM positions and 0 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Velan Capital Investment Management, adding an estimated $3.22M. The largest seller was BlackRock, cutting an estimated $30.6K.
- 18 institutional investors held Alimera Sciences (ALIM) as of Q2 2023, up from 16 in Q1 2023.
- Funds reported $10.3M of Alimera Sciences stock for Q2 2023, up 138% quarter-over-quarter.
- 2 funds opened new Alimera Sciences positions in Q2 2023 and 0 closed out, a net change of +2 holders.
- The largest Alimera Sciences buyer in Q2 2023 was Velan Capital Investment Management, an estimated $3.22M added.
- The largest Alimera Sciences seller in Q2 2023 was BlackRock, an estimated $30.6K sold.
Based on aggregated 13F filings for Q2 2023.